600 patients66,869 observations120 daysLIVE

Patient P-01430

Synthetic patientNBL-101 · Day 95 · 45–54 · F · baseline S05Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
17%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S05
  2. Day 23 CR-01 recommendedClinician Review CR-01
  3. Day 24 Patient acceptedStarted CR-01 in the companion
  4. Day 29 Deterioration detected before clinical escalationClinician Review CR-01

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • GI instability-12
  • Nutritional resilience+8
  • Treatment adherence-5
  • Toxicity+5

What helped?

  • Clinician Review CR-01Day 23
    Result: deterioration detected before clinical escalation
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
20.6/100
worsening · +4.1 vs previous 14 d
Toxicity
Blood
21.9/100
stable · -0.5 vs previous 14 d
Sleep quality
Wearable
25.7/100
stable · +0.6 vs previous 14 d
Energy level
Daily log
5.9/10
stable · +0.2 vs previous 14 d
Stress level
Daily log
5.3/10
worsening · +0.3 vs previous 14 d
Steps
Wearable
7,611
stable · +45 vs previous 14 d
Adherence
Companion
89.6 %
stable · -0.4 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 67 from the failing basin, 26 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
Would not help
  • Keep spicy low
    GI +4.6 next day on high-intake days · n 16
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Spicy / capsaicin
    +4.6detractor · 95%
  • Alcohol
    +1.4no signal · 26%
  • Insoluble fibre
    +1.2no signal · 26%
  • Dietary fat load
    +0.5no signal · 15%
  • Histamine load
    +0.4no signal · 15%
  • Simple carbohydrates
    0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Autonomic recovery 45
    • WearableResting HR 76 bpm
    • WearableShort sleep window
  • Mucosal barrier integrity 40
    • MicrobiomeAkkermansia low → thinner mucus layer
    • WearableSleep 6.1 h, below personal baseline
  • Inflammatory signalling 40
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • WearableHRV 36 ms, trending down
  • Drug metabolism and exposure 40
    • DNACYP2D6 poor metabolizer → higher exposure
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Poor metabolizer
    Higher exposure at standard dose
Microbiome
Shannon diversity 4.1 · butyrate capacity 82/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisNormal
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
36 ms
Sleep
6.2 h
Steps
7,521
Resting HR
78 bpm
Daily log: GI score 21, nutritional resilience 66, adherence 90.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Keep fibre steady; no new sources this week
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0155828%S0986
P-0142028%S0385
P-0166527%S0683
P-0153027%S1683
P-0143527%S0382
P-0138430%S0882
P-0146030%S1282
P-0152528%S1982
P-0177029%S1382
P-0167629%S0381
P-0151227%S1781
P-0180329%S1181